Dermacell Porous

Dermacell® Porous
Human ADM containing growth factors
Dermacell Porous is a thin yet durable, naturally porous, human ADM containing native growth factors, extracellular matrix, and collagen ratios found in human dermis providing enhanced vascularization and cell infiltration.1-4
- Non-sided graft for easy handling and application.
- Stored at room temperature and ready to use.5
- Can be used over exposed bone, ligament, muscle, and tendon.
- Proven to close in four or fewer applications.6
The Porous Advantage
Faster full incorporation with enhanced vascularization and cell infiltration.4
Intact dermal structure retains native extracellular matrix, endogenous growth factors, and collagen ratios found in human dermis.1-2
Naturally porous with the basement membrane removed.5
Clinical Application
- Chronic wounds such as diabetic foot ulcers (DFUs), venous stasis ulcers (VSUs), arterial ulcers, pressure ulcers, dehisced surgical wounds, and traumatic burns.
- Dermacell Porous can be placed over exposed tendon, bone, joint capsule, and muscle.
Order Code | Description | Sizing |
---|---|---|
DP-03 | Naturally Porous | 1.8 cm x 1.8 cm (0.2 – 0.5 mm) |
DP-06 | Naturally Porous | 2 cm x 3 cm (0.2 – 0.5 mm) |
DP-12 | Naturally Porous | 3 cm x 4 cm (0.2 – 0.5 mm) |
DP-25 | Naturally Porous | 5 cm x 5 cm (0.2 – 0.5 mm) |
DP-42 | Naturally Porous | 6 cm x 7 cm (0.2 – 0.5 mm) |
References
- 68-20-047, Analysis of the Acellular Matrix, Growth Factors, and Cytokines Present in Oracell.
- LifeNet Health, TR 0292, LifeNet Health’s Decellularized Dermis, Dermacell, Comparison to the USP Monograph, Scaffold Human Dermis.
- LifeNet Health, ED-22-038, Cytotoxicity Extraction Buffer Volume Comparison for Varying Thicknesses of Dermis.
- LifeNet Health, TR ED-23-0306, In vivo Assessment of Local Tissue Response and Cell Infiltration – Animal study results may not be predictive of clinical results.
- Moore MA, Samsell B, Wallis G, et al. Decellularization of human dermis using non-denaturing anionic detergent and endonuclease: a review. Cell Tissue Bank. 2015; 16(2):249-259. https://doi.org/10.1007/s10561-014-9467-4
- Cazzell, S., Vayser, D., Pham H., et al. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator. Wound Repair and Regeneration. 2017.